Paper Details 
Original Abstract of the Article :
Imatinib mesylate and perifosine are two relatively new drugs that have improved outcomes for patients with gastrointestinal stromal tumors in recent years. The ocular side effects of these two drugs are discussed in this chapter. The most common ocular side effect associated with imatinib mesylate ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.hoc.2008.11.003

データ提供:米国国立医学図書館(NLM)

Ocular Side Effects Associated with Imatinib Mesylate and Perifosine

Navigating the complex terrain of cancer treatments is always a delicate dance between effectiveness and side effects. This study focuses on two relatively new drugs, imatinib mesylate and perifosine, used to treat gastrointestinal stromal tumors. While these medications offer hope to patients, they come with potential ocular side effects. These side effects, like unwelcome desert mirages, can impact the quality of life for patients. This research helps us understand the potential risks associated with these treatments.

The Importance of Monitoring Ocular Side Effects

The study reveals that the most common ocular side effect associated with imatinib mesylate is periorbital edema, a swelling around the eyes. This is like a desert oasis appearing and disappearing, causing temporary discomfort. Perifosine, on the other hand, has been linked to a ring-shaped ulceration around the cornea, a protective layer on the eye. This is like a sandstorm impacting the surface of a fragile oasis. Both side effects require careful monitoring and appropriate treatment. This research emphasizes the importance of vigilant observation of patients receiving these medications, ensuring their well-being while optimizing treatment effectiveness.

The Need for Continued Research

This research highlights the need for ongoing research into the ocular side effects of new cancer treatments. Just as a seasoned traveler carefully plans their route through the desert, we must continue to investigate potential side effects to ensure the safety and well-being of our patients. By carefully studying the effects of these medications, we can better navigate the complexities of cancer treatment and provide patients with the best possible care.

Dr. Camel's Conclusion

The desert of cancer treatment is a challenging landscape, but with careful observation and innovative research, we can find ways to navigate it safely. By understanding the potential side effects of new medications, we can provide our patients with the best possible care while optimizing treatment effectiveness. This research is a reminder that even in the face of adversity, we can continue to make progress in the fight against disease.

Date :
  1. Date Completed 2009-04-29
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

19248974

DOI: Digital Object Identifier

10.1016/j.hoc.2008.11.003

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.